Report for Abhishek(25Y/M)

Tests asked Comprehensive Full Body Checkup With Vitamin D And B12 - New,

Esr + 1 Others

Test date 08 Jul 2024 Report status Complete Report

Name : ABHISHEK(25Y/M) ADDRESS :
Ref. By : SELF 14 SRI RANGANATHA NILAYA 5TH D CROSS INDIRA
COLONY BCC LAYOUT ATTIGUPPE ATTIGUPPE
NEAR SRI PANCHAMUKHI ANJANEYA TEMPLE
VIJAYNAGAR BENGALURU

Report Availability Summary

Full Report Available
Note : This is summary page. Please refer to the table below for the details

Test Report Status

CARDIAC RISK MARKERS Available

COMPREHENSIVE FULL BODY CHECKUP WITH VITAMIN D AND B12 - NEW Available

25-OH VITAMIN D (TOTAL) Available

COMPLETE URINE ANALYSIS Available

FASTING BLOOD SUGAR(GLUCOSE) Available

HbA1c Available

HEMOGRAM - 6 PART (DIFF) Available

IRON Available

KIDPRO Available

LIPID PROFILE Available

LIVER FUNCTION TESTS Available

TOTAL IRON BINDING CAPACITY (TIBC) Available

TOTAL THYROXINE (T4) Available

TOTAL TRIIODOTHYRONINE (T3) Available

TSH - ULTRASENSITIVE Available

UNSAT.IRON-BINDING CAPACITY(UIBC) Available

VITAMIN B-12 Available

ERYTHROCYTE SEDIMENTATION RATE (ESR) Available

Note : Underlined values are Critical Values, Clinician's attention required. Clinically Tested by : Thyrocare Technologies Ltd.
 NAME : ABHISHEK(25Y/M) HOME COLLECTION :
REF. BY : SELF 14 SRI RANGANATHA NILAYA 5TH D CROSS
INDIRA COLONY BCC LAYOUT ATTIGUPPE
TEST ASKED : CARDIAC RISK MARKERS,COMPREHENSIVE FULL BODY ATTIGUPPE NEAR SRI PANCHAMUKHI ANJANEYA
CHECKUP WITH VITAMIN D AND B12 - NEW,ESR TEMPLE VIJAYNAGAR BENGALURU

TEST NAME TECHNOLOGY VALUE UNITS

HbA1c - (HPLC)

H.P.L.C 5.3 %

Bio. Ref. Interval. :

Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control

Method : Fully Automated H.P.L.C method

AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 105 mg/dL

Bio. Ref. Interval. :

90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control

Method : Derived from HBA1c values

Please correlate with clinical conditions.

Sample Collected on (SCT) : 08 Jul 2024 07:04

Sample Received on (SRT) : 08 Jul 2024 11:20
Report Released on (RRT) : 08 Jul 2024 14:09

Sample Type : EDTA Whole Blood

Labcode : 0807040254/DG007 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : CM333607
Page : 1 of 16
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : ABHISHEK(25Y/M) HOME COLLECTION :

REF. BY : SELF 14 SRI RANGANATHA NILAYA 5TH D CROSS INDIRA

COLONY BCC LAYOUT ATTIGUPPE ATTIGUPPE NEAR
TEST ASKED : CARDIAC RISK MARKERS,COMPREHENSIVE FULL BODY SRI PANCHAMUKHI ANJANEYA TEMPLE VIJAYNAGAR
CHECKUP WITH VITAMIN D AND B12 - NEW,ESR BENGALURU
TEST NAME TECHNOLOGY VALUE UNITS
ERYTHROCYTE SEDIMENTATION RATE (ESR) MODIFIED WESTERGREN 28 mm / hr
Bio. Ref. Interval. :-

Male : 0-15
Female : 0-20

Please correlate with clinical conditions.

Method:- MODIFIED WESTERGREN

Sample Collected on (SCT) : 08 Jul 2024 07:04

Sample Received on (SRT) : 08 Jul 2024 11:20
Report Released on (RRT) : 08 Jul 2024 14:09

Sample Type : EDTA Whole Blood

Labcode : 0807040254/DG007 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : CM333607 Page : 2 of 16

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : ABHISHEK(25Y/M) HOME COLLECTION :
REF. BY : SELF 14 SRI RANGANATHA NILAYA 5TH D CROSS
INDIRA COLONY BCC LAYOUT ATTIGUPPE
TEST ASKED : CARDIAC RISK MARKERS,COMPREHENSIVE FULL BODY
ATTIGUPPE NEAR SRI PANCHAMUKHI ANJANEYA
CHECKUP WITH VITAMIN D AND B12 - NEW,ESR TEMPLE VIJAYNAGAR BENGALURU

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL LEUCOCYTES COUNT (WBC) HF & FC 6.59 X 10³ / µL 4.0 - 10.0
NEUTROPHILS Flow Cytometry 60.5 % 40-80
LYMPHOCYTE Flow Cytometry 35.2 % 20-40
MONOCYTES Flow Cytometry 3.6 % 2-10
EOSINOPHILS Flow Cytometry 0.2 % 1-6
BASOPHILS Flow Cytometry 0.2 % 0-2
IMMATURE GRANULOCYTE PERCENTAGE(IG%) Flow Cytometry 0.3 % 0-0.5
NEUTROPHILS - ABSOLUTE COUNT Calculated 3.99 X 10³ / µL 2.0-7.0
LYMPHOCYTES - ABSOLUTE COUNT Calculated 2.32 X 10³ / µL 1.0-3.0
MONOCYTES - ABSOLUTE COUNT Calculated 0.24 X 10³ / µL 0.2 - 1.0
BASOPHILS - ABSOLUTE COUNT Calculated 0.01 X 10³ / µL 0.02 - 0.1
EOSINOPHILS - ABSOLUTE COUNT Calculated 0.01 X 10³ / µL 0.02 - 0.5
IMMATURE GRANULOCYTES(IG) Calculated 0.02 X 10³ / µL 0-0.3
TOTAL RBC HF & EI 5.06 X 10^6/µL 4.5-5.5
NUCLEATED RED BLOOD CELLS Calculated 0.01 X 10³ / µL 0.0-0.5
NUCLEATED RED BLOOD CELLS % Flow Cytometry 0.01 % 0.0-5.0
HEMOGLOBIN SLS-Hemoglobin Method 13.8 g/dL 13.0-17.0
HEMATOCRIT(PCV) CPH Detection 42.1 % 40.0-50.0
MEAN CORPUSCULAR VOLUME(MCV) Calculated 83.2 fL 83.0-101.0
MEAN CORPUSCULAR HEMOGLOBIN(MCH) Calculated 27.3 pq 27.0-32.0
MEAN CORP.HEMO.CONC(MCHC) Calculated 32.8 g/dL 31.5-34.5
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) Calculated 35.3 fL 39-46
RED CELL DISTRIBUTION WIDTH (RDW-CV) Calculated 11.8 % 11.6-14
PLATELET DISTRIBUTION WIDTH(PDW) Calculated 9.6 fL 9.6-15.2
MEAN PLATELET VOLUME(MPV) Calculated 9.3 fL 6.5-12
PLATELET COUNT HF & EI 214 X 10³ / µL 150-410
PLATELET TO LARGE CELL RATIO(PLCR) Calculated 18.8 % 19.7-42.4
PLATELETCRIT(PCT) Calculated 0.2 % 0.19-0.39
Remarks : Alert!!! Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.

Clinical history is asked for all the relevant abnormalities detected and in absence / failure of receiving of clinical history,
results are rechecked twice and released. Advised clinical correlation.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

Sample Collected on (SCT) : 08 Jul 2024 07:04

Sample Received on (SRT) : 08 Jul 2024 11:20
Report Released on (RRT) : 08 Jul 2024 14:09
Sample Type : EDTA Whole Blood
Labcode : 0807040254/DG007 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : CM333607 Page : 3 of 16

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
 NAME : ABHISHEK(25Y/M) HOME COLLECTION :

REF. BY : SELF 14 SRI RANGANATHA NILAYA 5TH D CROSS INDIRA

COLONY BCC LAYOUT ATTIGUPPE ATTIGUPPE NEAR
TEST ASKED : CARDIAC RISK MARKERS,COMPREHENSIVE FULL BODY SRI PANCHAMUKHI ANJANEYA TEMPLE VIJAYNAGAR
CHECKUP WITH VITAMIN D AND B12 - NEW,ESR BENGALURU
TEST NAME TECHNOLOGY VALUE UNITS
FASTING BLOOD SUGAR(GLUCOSE) PHOTOMETRY 90.8 mg/dL

Bio. Ref. Interval. :-

As per ADA Guideline: Fasting Plasma Glucose (FPG)

Normal 70 to 100 mg/dl

Prediabetes 100 mg/dl to 125 mg/dl

Diabetes 126 mg/dl or higher

Note :
The assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed ,
icteric or lipemic. The concentration of Glucose in a given specimen may vary due to differences in assay methods, calibration and
reagent specificity. For diagnostic purposes results should always be assessed in conjunction with patients medical history, clinical
findings and other findings.

Please correlate with clinical conditions.

Method:- GOD-PAP METHOD

Sample Collected on (SCT) : 08 Jul 2024 07:04

Sample Received on (SRT) : 08 Jul 2024 11:00
Report Released on (RRT) : 08 Jul 2024 12:25

Sample Type : FLUORIDE

Labcode : 0807063912/DG007 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : CO419718 Page : 4 of 16

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : ABHISHEK(25Y/M) HOME COLLECTION :
REF. BY : SELF 14 SRI RANGANATHA NILAYA 5TH D CROSS INDIRA
TEST ASKED : CARDIAC RISK MARKERS,COMPREHENSIVE FULL BODY COLONY BCC LAYOUT ATTIGUPPE ATTIGUPPE NEAR
SRI PANCHAMUKHI ANJANEYA TEMPLE VIJAYNAGAR
CHECKUP WITH VITAMIN D AND B12 - NEW,ESR
BENGALURU

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

Complete Urinogram
Physical Examination
VOLUME Visual Determination 3 mL -
COLOUR Visual Determination PALE YELLOW - Pale Yellow
APPEARANCE Visual Determination CLEAR - Clear
SPECIFIC GRAVITY pKa change 1.015 - 1.003-1.030
PH pH indicator 6 - 5-8
Chemical Examination
URINARY PROTEIN PEI ABSENT mg/dL Absent
URINARY GLUCOSE GOD-POD ABSENT mg/dL Absent
URINE KETONE Nitroprusside ABSENT mg/dL Absent
URINARY BILIRUBIN Diazo coupling ABSENT mg/dL Absent
UROBILINOGEN Diazo coupling Normal mg/dL <=0.2
BILE SALT Hays sulphur ABSENT - Absent
BILE PIGMENT Ehrlich reaction ABSENT - Absent
URINE BLOOD Peroxidase reaction ABSENT - Absent
NITRITE Diazo coupling ABSENT - Absent
LEUCOCYTE ESTERASE Esterase reaction ABSENT - Absent
Microscopic Examination
MUCUS Microscopy ABSENT - Absent
RED BLOOD CELLS Microscopy ABSENT cells/HPF 0-5
URINARY LEUCOCYTES (PUS CELLS) Microscopy ABSENT cells/HPF 0-5
EPITHELIAL CELLS Microscopy 3 cells/HPF 0-5
CASTS Microscopy ABSENT - Absent
CRYSTALS Microscopy ABSENT - Absent
BACTERIA Microscopy ABSENT - Absent
YEAST Microscopy ABSENT - Absent
PARASITE Microscopy ABSENT - Absent

(Reference : *PEI - Protein error of indicator, *GOD-POD - Glucose oxidase-peroxidase)

Sample Collected on (SCT) : 08 Jul 2024 07:04

Sample Received on (SRT) : 08 Jul 2024 12:13
Report Released on (RRT) : 08 Jul 2024 13:39
Sample Type : URINE
Labcode : 0807069152/DG007 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : CJ553619 Page : 5 of 16

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
 NAME : ABHISHEK(25Y/M) HOME COLLECTION :
REF. BY : SELF 14 SRI RANGANATHA NILAYA 5TH D CROSS
INDIRA COLONY BCC LAYOUT ATTIGUPPE
TEST ASKED : CARDIAC RISK MARKERS,COMPREHENSIVE FULL BODY ATTIGUPPE NEAR SRI PANCHAMUKHI ANJANEYA
CHECKUP WITH VITAMIN D AND B12 - NEW,ESR TEMPLE VIJAYNAGAR BENGALURU

TEST NAME TECHNOLOGY VALUE UNITS

25-OH VITAMIN D (TOTAL) E.C.L.I.A 14.7 ng/mL

Bio. Ref. Interval. :

Deficiency : <=20 ng/ml || Insufficiency : 21-29 ng/ml

Sufficiency : >= 30 ng/ml || Toxicity : >100 ng/ml

Clinical Significance:
Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous;
both are critical for building bone health.
Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic syndrome.
Increase in vitamin D total levels indicate Vitamin D intoxication.

Specifications: Precision: Intra assay (%CV):9.20%, Inter assay (%CV):8.50%

Kit Validation Reference : Holick M. Vtamin D the underappreciated D-Lightful hormone that is important for Skeletal
and cellular health Curr Opin Endocrinol Diabetes 2002:9(1)87-98.
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay

VITAMIN B-12 E.C.L.I.A 134 pg/mL

Bio. Ref. Interval. :

Normal: 197-771 pg/ml

Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as
meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the
formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis
associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in conjunction with the
patients medical history, clinical examination and other findings.

Specifications: Intra assay (%CV):2.6%, Inter assay (%CV):2.3 %

Kit Validation Reference : Thomas L.Clinical laborator Diagnostics : Use and Assessment of Clinical laboratory Results 1st
Edition,TH Books-Verl-Ges,1998:424-431
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay

Please correlate with clinical conditions.

Sample Collected on (SCT) : 08 Jul 2024 07:04

Sample Received on (SRT) : 08 Jul 2024 11:26
Report Released on (RRT) : 08 Jul 2024 15:27

Sample Type : SERUM

Labcode : 0807064086/DG007 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : CM764294
Page : 6 of 16
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
 NAME : ABHISHEK(25Y/M) HOME COLLECTION :
REF. BY : SELF 14 SRI RANGANATHA NILAYA 5TH D CROSS
INDIRA COLONY BCC LAYOUT ATTIGUPPE
TEST ASKED : CARDIAC RISK MARKERS,COMPREHENSIVE FULL BODY ATTIGUPPE NEAR SRI PANCHAMUKHI ANJANEYA
CHECKUP WITH VITAMIN D AND B12 - NEW,ESR TEMPLE VIJAYNAGAR BENGALURU

TEST NAME TECHNOLOGY VALUE UNITS

APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 117 mg/dL

Bio. Ref. Interval. :

Male : 86 - 152
Female : 94 - 162
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER

APOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 73 mg/dL

Bio. Ref. Interval. :

Male : 56 - 145
Female : 53 - 138
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER

APO B / APO A1 RATIO (APO B/A1) CALCULATED 0.6 Ratio

Bio. Ref. Interval. :

Male : 0.40 - 1.26

Female : 0.38 - 1.14
Method : Derived from serum Apo A1 and Apo B values

Please correlate with clinical conditions.

Sample Collected on (SCT) : 08 Jul 2024 07:04

Sample Received on (SRT) : 08 Jul 2024 11:26
Report Released on (RRT) : 08 Jul 2024 15:27

Sample Type : SERUM

Labcode : 0807064086/DG007 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : CM764294
Page : 7 of 16
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : ABHISHEK(25Y/M) HOME COLLECTION :

REF. BY : SELF 14 SRI RANGANATHA NILAYA 5TH D CROSS INDIRA

COLONY BCC LAYOUT ATTIGUPPE ATTIGUPPE NEAR
TEST ASKED : CARDIAC RISK MARKERS,COMPREHENSIVE FULL BODY SRI PANCHAMUKHI ANJANEYA TEMPLE VIJAYNAGAR
CHECKUP WITH VITAMIN D AND B12 - NEW,ESR BENGALURU
TEST NAME TECHNOLOGY VALUE UNITS
HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 30.55 mg/L
Bio. Ref. Interval. :-

< 1.00 - Low Risk

1.00 - 3.00 - Average Risk
>3.00 - 10.00 - High Risk
> 10.00 - Possibly due to Non-Cardiac Inflammation

Disclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as
infection , active arthritis or concurrent illness.

Clinical significance:
High sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk
for future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP
tests, ideally taken two weeks apart.

Kit Validation Reference:

1.Clinical management of laboratory date in medical practice 2003-3004, 207(2003).
2.Tietz : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47:Page no.1507- 1508.

Please correlate with clinical conditions.

Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER

Sample Collected on (SCT) : 08 Jul 2024 07:04

Sample Received on (SRT) : 08 Jul 2024 11:26
Report Released on (RRT) : 08 Jul 2024 15:27

Sample Type : SERUM

Labcode : 0807064086/DG007 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : CM764294 Page : 8 of 16

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
 NAME : ABHISHEK(25Y/M) HOME COLLECTION :

REF. BY : SELF 14 SRI RANGANATHA NILAYA 5TH D CROSS INDIRA

COLONY BCC LAYOUT ATTIGUPPE ATTIGUPPE NEAR
TEST ASKED : CARDIAC RISK MARKERS,COMPREHENSIVE FULL BODY SRI PANCHAMUKHI ANJANEYA TEMPLE VIJAYNAGAR
CHECKUP WITH VITAMIN D AND B12 - NEW,ESR BENGALURU
TEST NAME TECHNOLOGY VALUE UNITS
Lipoprotein (a) [Lp(a)] IMMUNOTURBIDIMETRY <2 mg/dL
Bio. Ref. Interval. :-

Adults : < 30.0 mg/dl

Clinical Significance:
Determination of LPA may be useful to guide management of individuals with a family history of CHD or with existing disease. The
levels of LPA in the blood depends on genetic factors; The range of variation in a population is relatively large and hence for
diagnostic purpose, results should always be assessed in conjunction with the patient’s medical history, clinical examination and
other findings.

Specifications:
Precision %CV :- Intra assay %CV- 4.55% , Inter assay %CV-0.86 %

Kit Validation Reference:

Tietz NW,Clinical Guide to Laboratory Tests Philadelphia WB. Saunders 1995 : 442-444

Please correlate with clinical conditions.

Method:- LATEX ENHANCED IMMUNOTURBIDIMETRY

Sample Collected on (SCT) : 08 Jul 2024 07:04

Sample Received on (SRT) : 08 Jul 2024 11:26
Report Released on (RRT) : 08 Jul 2024 15:27

Sample Type : SERUM

Labcode : 0807064086/DG007 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : CM764294 Page : 9 of 16

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : ABHISHEK(25Y/M) HOME COLLECTION :
REF. BY : SELF 14 SRI RANGANATHA NILAYA 5TH D CROSS
INDIRA COLONY BCC LAYOUT ATTIGUPPE
TEST ASKED : CARDIAC RISK MARKERS,COMPREHENSIVE FULL BODY ATTIGUPPE NEAR SRI PANCHAMUKHI ANJANEYA
CHECKUP WITH VITAMIN D AND B12 - NEW,ESR TEMPLE VIJAYNAGAR BENGALURU

TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 35.8 µg/dL

Bio. Ref. Interval. :

Male : 65 - 175
Female : 50 - 170
Method : Ferrozine method without deproteinization

TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 303.2 µg/dL

Bio. Ref. Interval. :

Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl

Method : Spectrophotometric Assay

% TRANSFERRIN SATURATION CALCULATED 11.81 %

Bio. Ref. Interval. :

13 - 45

Method : Derived from IRON and TIBC values

UNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 267.4 µg/dL

Bio. Ref. Interval. :

162 - 368

Method : SPECTROPHOTOMETRIC ASSAY

Please correlate with clinical conditions.

Sample Collected on (SCT) : 08 Jul 2024 07:04

Sample Received on (SRT) : 08 Jul 2024 11:26
Report Released on (RRT) : 08 Jul 2024 15:27

Sample Type : SERUM

Labcode : 0807064086/DG007 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : CM764294
Page : 10 of 16
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
 NAME : ABHISHEK(25Y/M) HOME COLLECTION :
REF. BY 14 SRI RANGANATHA NILAYA 5TH D CROSS INDIRA
: SELF
COLONY BCC LAYOUT ATTIGUPPE ATTIGUPPE NEAR SRI
TEST ASKED : CARDIAC RISK MARKERS,COMPREHENSIVE FULL BODY PANCHAMUKHI ANJANEYA TEMPLE VIJAYNAGAR
CHECKUP WITH VITAMIN D AND B12 - NEW,ESR BENGALURU

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL CHOLESTEROL PHOTOMETRY 139 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 56 mg/dL 40-60
HDL / LDL RATIO CALCULATED 0.82 Ratio > 0.40
LDL CHOLESTEROL - DIRECT PHOTOMETRY 68 mg/dL < 100
TC/ HDL CHOLESTEROL RATIO CALCULATED 2.5 Ratio 3-5
TRIG / HDL RATIO CALCULATED 1.31 Ratio < 3.12
TRIGLYCERIDES PHOTOMETRY 74 mg/dL < 150
LDL / HDL RATIO CALCULATED 1.2 Ratio 1.5-3.5
NON-HDL CHOLESTEROL CALCULATED 83.21 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 14.72 mg/dL 5 - 40
Please correlate with clinical conditions.

Method :

CHOL - Cholesterol Oxidase, Esterase, Peroxidase

HCHO - Direct Enzymatic Colorimetric
HD/LD - Derived from HDL and LDL values.
LDL - Direct Measure
TC/H - Derived from serum Cholesterol and Hdl values
TRI/H - Derived from TRIG and HDL Values
TRIG - Enzymatic, End Point
LDL/ - Derived from serum HDL and LDL Values
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values

*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:

TOTAL CHOLESTEROL LDL (mg/dl) TRIGLYCERIDES

(mg/dl) HDL (mg/dl) (mg/dl)

DESIRABLE <200 LOW OPTIMAL <100 NORMAL <150

<40

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199

HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499

HIGH 160-189 VERY HIGH >500

VERY HIGH >190

Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Collected on (SCT) : 08 Jul 2024 07:04

Sample Received on (SRT) : 08 Jul 2024 11:26
Report Released on (RRT) : 08 Jul 2024 15:27

Sample Type : SERUM

Labcode : 0807064086/DG007 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : CM764294
Page : 11 of 16
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
 NAME : ABHISHEK(25Y/M) HOME COLLECTION :
REF. BY 14 SRI RANGANATHA NILAYA 5TH D CROSS INDIRA
: SELF
COLONY BCC LAYOUT ATTIGUPPE ATTIGUPPE NEAR SRI
TEST ASKED : CARDIAC RISK MARKERS,COMPREHENSIVE FULL BODY PANCHAMUKHI ANJANEYA TEMPLE VIJAYNAGAR
CHECKUP WITH VITAMIN D AND B12 - NEW,ESR BENGALURU

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

ALKALINE PHOSPHATASE PHOTOMETRY 76.31 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.31 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.06 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.25 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 12 U/L < 55
SGOT / SGPT RATIO CALCULATED 1.18 Ratio <2
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 22.85 U/L < 35
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 19.3 U/L < 45
PROTEIN - TOTAL PHOTOMETRY 6.69 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 3.92 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 2.77 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.42 Ratio 0.9 - 2
Please correlate with clinical conditions.

Method :

ALKP - Modified IFCC method

BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
OT/PT - Derived from SGOT and SGPT values.
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Collected on (SCT) : 08 Jul 2024 07:04

Sample Received on (SRT) : 08 Jul 2024 11:26
Report Released on (RRT) : 08 Jul 2024 15:27

Sample Type : SERUM

Labcode : 0807064086/DG007 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : CM764294
Page : 12 of 16
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : ABHISHEK(25Y/M) HOME COLLECTION :
REF. BY 14 SRI RANGANATHA NILAYA 5TH D CROSS INDIRA
: SELF
COLONY BCC LAYOUT ATTIGUPPE ATTIGUPPE NEAR SRI
TEST ASKED : CARDIAC RISK MARKERS,COMPREHENSIVE FULL BODY PANCHAMUKHI ANJANEYA TEMPLE VIJAYNAGAR
CHECKUP WITH VITAMIN D AND B12 - NEW,ESR BENGALURU

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

UREA (CALCULATED) CALCULATED 18.53 mg/dL Adult : 17-43
BLOOD UREA NITROGEN (BUN) PHOTOMETRY 8.66 mg/dL 7.94 - 20.07
UREA / SR.CREATININE RATIO CALCULATED 26.86 Ratio < 52
CREATININE - SERUM PHOTOMETRY 0.69 mg/dL 0.72-1.18
BUN / SR.CREATININE RATIO CALCULATED 12.55 Ratio 9:1-23:1
CALCIUM PHOTOMETRY 9.1 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 4.01 mg/dL 4.2 - 7.3
Please correlate with clinical conditions.

Method :

UREAC - Derived from BUN Value.

BUN - Kinetic UV Assay.
UR/CR - Derived from UREA and Sr.Creatinine values.
SCRE - Creatinine Enzymatic Method
B/CR - Derived from serum Bun and Creatinine values
CALC - Arsenazo III Method, End Point.
URIC - Uricase / Peroxidase Method

Sample Collected on (SCT) : 08 Jul 2024 07:04

Sample Received on (SRT) : 08 Jul 2024 11:26
Report Released on (RRT) : 08 Jul 2024 15:27

Sample Type : SERUM

Labcode : 0807064086/DG007 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : CM764294
Page : 13 of 16
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
 NAME : ABHISHEK(25Y/M) HOME COLLECTION :
14 SRI RANGANATHA NILAYA 5TH D CROSS INDIRA
REF. BY : SELF
COLONY BCC LAYOUT ATTIGUPPE ATTIGUPPE NEAR SRI
TEST ASKED : CARDIAC RISK MARKERS,COMPREHENSIVE FULL BODY PANCHAMUKHI ANJANEYA TEMPLE VIJAYNAGAR
CHECKUP WITH VITAMIN D AND B12 - NEW,ESR BENGALURU

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL TRIIODOTHYRONINE (T3) E.C.L.I.A 116 ng/dL 80-200

TOTAL THYROXINE (T4) E.C.L.I.A 7.67 µg/dL 4.8-12.7
TSH - ULTRASENSITIVE E.C.L.I.A 2.92 µIU/mL 0.54-5.30

Comments : SUGGESTING THYRONORMALCY

The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :
T3 - Fully Automated Electrochemiluminescence Compititive Immunoassay
T4 - Fully Automated Electrochemiluminescence Compititive Immunoassay
USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay

Disclaimer :

Results should always be interpreted using the reference range provided by the laboratory that performed the test.
Different laboratories do tests using different technologies, methods and using different reagents which may cause difference
In reference ranges and hence it is recommended to interpret result with assay specific reference ranges provided in the reports.
To diagnose and monitor therapy doses, it is recommended to get tested every time at the same Laboratory.

Sample Collected on (SCT) : 08 Jul 2024 07:04

Sample Received on (SRT) : 08 Jul 2024 11:26
Report Released on (RRT) : 08 Jul 2024 15:27
Sample Type : SERUM
Labcode : 0807064086/DG007 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : CM764294 Page : 14 of 16

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
 NAME : ABHISHEK(25Y/M) HOME COLLECTION :

REF. BY : SELF 14 SRI RANGANATHA NILAYA 5TH D CROSS INDIRA

COLONY BCC LAYOUT ATTIGUPPE ATTIGUPPE NEAR
TEST ASKED : CARDIAC RISK MARKERS,COMPREHENSIVE FULL BODY SRI PANCHAMUKHI ANJANEYA TEMPLE VIJAYNAGAR
CHECKUP WITH VITAMIN D AND B12 - NEW,ESR BENGALURU
TEST NAME TECHNOLOGY VALUE UNITS
EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 132 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- CKD-EPI Creatinine Equation

~~ End of report ~~

Sample Collected on (SCT) : 08 Jul 2024 07:04

Sample Received on (SRT) : 08 Jul 2024 11:26
Report Released on (RRT) : 08 Jul 2024 15:27

Sample Type : SERUM

Labcode : 0807064086/DG007 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : CM764294 Page : 15 of 16

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the
same patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Docon Technologies Private Limited,Thyrocare Technologies Limited and its employees/representatives do not
assume any liability,responsibility for any loss or damage that may be incurred by any person as a result of
presuming the meaning or contents of the report.

EXPLANATIONS

v Name - The name is as declared by the client and recorded by the personnel who collected the specimen.
v Ref.By - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing the
barcode (irrespective of the name).
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS

v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v For suggestions, complaints or feedback, write to us at grievance-office@docon.co.in or call us on 7022000900.

Page : 16 of 16